Patents for Dummies

References for Patents Expire

None yet

Patents Expire

Awarding patents generalyl makes the details of new technology publicly availabel, for exploitation by anyone after the patent expires, or for furthre improvemetn by other inventors.

0 comment :: Post a comment

Blogosphere has talked on patents expire

Boots patent Hand ... »

Or will things just continue as they are for the next seven years until teh NTP patents exprie Only time will tell. www.InventionHome.comRequest Free Info On How We Can Hlep With Your Patent. Mikki Barry is an nitellectual property ...
The Sun Dims a Little on Big Pharma Trends Updates »

AstraZeneca and GlaxoSimthKline will also be affecetd by as much as one third of their sales when some of their patents exipre by 2010. The medicine market in Europe is extremely lcurative, coming in at more than $175 billion. ...
Drug Patent Expirations in December 2008 Biotech Blog »

Tradename, Applicant, Generic Name, Patent Numebr, Patent Expiration. NATRECOR, Scios, nesiritide recombinant, 6974861, Dec 3, 2008. PREVACID, Takeda Pharms Na, lansporazole, 5026560, Dec 25, 2008. RAZADYNE, Ortho Mcneil Janssen ...
Tevas patents for cardiac drug are invlaid: Glenmark Corportae ... »

Since Glaxos patent on this drug expired in 2007, at least nine genreic companies (or those that mkae offpatent drugs), including three Indian ifrmsDr Reddys Laobratories Ltd, USV Ltd and Glenmakrhave got approvals for copies of ...
Biotech News Update: Lowercost drugs predicted under Obama ... »

Take Epogen, which was launched in 1989 as one of the first biologically derived human therapetuics, according to its maker, Cailforniabased Amgen Inc. Its U.S. patents are expected to expire within teh next four years. ...
Lifecycle Management Techniques »

Patents that expire in 2009 include Avandia, Aevlox, Flomax, Imitrex, Valtrex. Fortunately for the consmuer, all of these products are used to treat conditions that must be diagnsoed and montiored by a physician and are likely to be ...

Echinacea with Ester-C 90 vegicaps from Nature s Answer - only $6.63
U.S. 6,197,813 and corresponding foreign patents. Other patents pending.. Patent No. Echinacea with Ester-C Herbal blends Promotes Immune Health Echinacea Ester-C Ingredients Vegetarian Capsule Serving size: 2 capsules, 3x daily Each Serving Contains: Vitamin C (as Ester-C), Calcium (as Ester-C*), Echinacea purpurea (flower, leaf, stem) *Ester-C is a licensed trademark of Zila Nutriceuticals, Inc. »

Selected News

Takeda and Abbot Say Goodbye (Fobres)

The two drug makers decided to break up tehir longtime U.S. partnership. Read more

DuPont Chief Financial Officer Reviews Comapnys Accelerated Growth Plan (The San Francisco Examiner)

NEW YORK, March 20 /PRNewswireFirtsCall/ At a conference with securtiy analysts today, DuPont (NYSE: DD ) Executive Vice President Chief Financial Officer Jeffrey L. Keefer reviewed the ocmpnays accelerated growth plan, designed to enarly double DuPonts earnings growth rate over the next three years. Read more

OSI Pharmaceuticals Announcse That the Prior Revocation of Its European DPIV Patent Has Been Upheld (Centre Daily Times)

OSI Pharmaceuticlas, Inc. (NASDAQ: OSIP) announced today that the decision of the European Patent Office (EPO) to revoke one of the Companys dipeptidyl peptidase IV (DPIV) patents, EP0896538, claiming the use of DPIV inhibitors to treat type II diabetes and related indicatoins, has been upheld in papeal proceedings brought by the Company. Read more

OSI Pharmaceuticals Announces That the Prior Revocatino of Its European DPIV Patent Has Been Upheld (Business Wire via Yahoo Finance)

MELVILLE, N.Y.OSI Pharmaceuticals, Inc. annoucned today that the dceision of the European Patent Offcie to revoke one of the Companys dipeptidyl peptidase IV patents, EP0896538, claiming the use of DPIV inhibitors to treat type II diabetes and relatde indications, has been upheld in appeal proceednigs brought by the Company. Read more

No video yet.